White Paper

Avoid Clinical Manufacturing Pitfalls With These Tech Transfer Best Practices

Pharma Manufacturing GettyImages-1135140594

Ensure a smooth transition from development to manufacturing by implementing a strategic tech transfer process. This article outlines key practices for effective communication, collaboration, and risk mitigation between biotech companies and CDMOs.

Moving a biopharmaceutical product from development to clinical trial manufacturing can be a daunting task. A successful tech transfer, however, can streamline this process and save both time and money. This article explores the importance of clear communication and collaboration between biotech companies and their contract development and manufacturing organizations (CDMOs).

We delve into the critical steps of tech transfer, from selecting the right CDMO partner to navigating potential supply chain risks. By outlining best practices for program management, process development, and workflow handoffs, this article provides a roadmap to a successful tech transfer for your next clinical biomanufacturing program.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online